What is Immunoprecise Antibodies Ltd (IPA)?

Immunoprecise Antibodies Ltd (IPA) Stock Analysis

$2.070

+0.150 (+7.25%)At close

Loading chart…

High: 2.235
Open: 2.000
VWAP: 2.10
Vol: 2.05M
Mkt Cap: 26.05M
Low: 2.000
Amount: 4.31M
EV/EBITDA, TTM: 0.00

MindWalk Holdings Corp., formerly ImmunoPrecise Antibodies Ltd., is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

www.ipatherapeutics.com

Valuation Metrics

The current forward P/E ratio for Immunoprecise Antibodies Ltd (IPA) is -22.40, compared to its 5-year average forward P/E of -3.27.

Forward P/E

Strongly Undervalued

5Y Average P/E

-3.27

Current P/E

-22.40

Overvalued

1.15

Undervalued

-7.69

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Fair

5Y Average P/S

3.97

Current P/S

4.38

Overvalued

6.59

Undervalued

1.36

Alphio AI Price Scenarios for IPA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Bull

Bull · 25%IPA

$0.64

Scenario price

Base

Base · 50%IPA

$0.64

Scenario price

Bear

Bear · 25%IPA

$0.59

Scenario price

Events Timeline

2025-09-03 (ET)